Most Recent

image: On Becoming Human

On Becoming Human

By | August 1, 2016

Some thoughts on going to the Galápagos

1 Comment

image: Research at Micro- and Nanoscales

Research at Micro- and Nanoscales

By | June 1, 2016

From whole cells to genes, closer examination continues to surprise.  

1 Comment

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: All Together Now

All Together Now

By | January 1, 2016

Understanding the biological roots of cooperation might help resolve some of the biggest scientific challenges we face.

1 Comment

image: Family Ties

Family Ties

By | December 1, 2015

There’s more to inheritance than genes.

3 Comments

image: Intelligence Gathering

Intelligence Gathering

By | July 1, 2015

Disease eradication in the 21st century

0 Comments

image: New Legs to Stand On

New Legs to Stand On

By | June 1, 2015

Reconstructing the past using ancient DNA

0 Comments

image: Hiding in the Haystack

Hiding in the Haystack

By | May 1, 2015

Encouraging developments in HIV research

0 Comments

image: To Each His Own

To Each His Own

By | April 1, 2015

Cancer treatment becomes more and more personal.

0 Comments

image: Head Scratchers

Head Scratchers

By | September 1, 2014

Many natural phenomena elude our understanding.

5 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham